GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 15 filers reported holding GAIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $295,200 | +73150.6% | 90,000 | 0.0% | 0.31% | -20.4% |
| Q2 2023 | $403 | -7.1% | 90,000 | 0.0% | 0.39% | -23.7% |
| Q1 2023 | $434 | +26.2% | 90,000 | -18.2% | 0.52% | +25.3% |
| Q4 2022 | $344 | -99.9% | 110,000 | -12.0% | 0.41% | -9.7% |
| Q3 2022 | $408,000 | -9.3% | 125,000 | 0.0% | 0.46% | -5.0% |
| Q2 2022 | $450,000 | -11.9% | 125,000 | 0.0% | 0.48% | +11.7% |
| Q1 2022 | $511,000 | +4.5% | 125,000 | +38.9% | 0.43% | +16.3% |
| Q4 2021 | $489,000 | +2.1% | 90,000 | +39.9% | 0.37% | +3.4% |
| Q3 2021 | $479,000 | +379.0% | 64,327 | +543.3% | 0.36% | +395.8% |
| Q2 2021 | $100,000 | – | 10,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|